Drugs Made In America Acquisition II Corp. 8-K

What Happened
Drugs Made In America Acquisition II Corp. (DMII) reported on Form 8-K (filed March 6, 2026) that its sponsor made improper withdrawals from the company’s working capital account between the completion of its IPO on September 26, 2025 and December 31, 2025. The board investigated and confirmed those irregularities did not affect the company’s trust account. As of March 6, 2026, the company says the Trust Account contains approximately $507,841,957.

Key Details

• IPO completion date: September 26, 2025.
• Period of improper sponsor withdrawals: between September 26, 2025 and December 31, 2025.
• Trust Account balance confirmed on March 6, 2026: approximately $507,841,957.
• Company action: board reviewed the issue and confirmed no impact to the Trust Account.

Why It Matters
For investors, the Trust Account balance is a key safeguard for a special-purpose acquisition company (SPAC) like DMII because funds in the trust are intended to protect public shareholders until a business combination. The company’s confirmation that roughly $507.8 million remains in the Trust Account indicates those protected funds were not affected by the sponsor’s improper withdrawals from working capital. Investors should watch for any further disclosures about remediation, potential recoveries, or regulatory actions related to the sponsor withdrawals.